4D Molecular Therapeutics reported cash from operations of -$70.00M and free cash flow of -$69.98M for the quarter ended Jun 2026, down 61.4% year over year. This cash flow statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||
| Net Income | -22.23M | -25.08M | -27.39M | -28.83M | -25.70M | -27.38M | -29.18M | -31.52M | -10.10M | -32.27M | -38.26M | -42.64M | -43.84M | -49.65M | -53.52M | -54.60M | -56.85M | 19.42M | -74.53M | -72.77M | |||||||
| Share-based CompensationStock Comp. | 4.08M | 3.73M | 4.83M | 5.02M | 6.04M | 4.35M | 6.59M | 6.42M | 6.02M | 5.91M | 8.23M | 8.19M | 8.83M | 7.58M | 10.66M | 10.45M | 9.68M | 5.55M | 11.54M | 11.74M | |||||||
| Cash from OperationsCash from Ops. | -15.72M | -21.84M | -23.55M | -19.90M | -21.02M | -22.21M | -27.91M | -22.07M | -1.17M | -24.65M | -29.09M | -30.24M | -29.39M | -45.86M | -47.76M | -43.38M | -46.50M | 28.55M | -68.12M | -70.00M | |||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.38M | 0.38M | -0.58M | -0.47M | -0.24M | 2.77M | 0.40M | 0.34M | 0.40M | 0.41M | 0.76M | 2.33M | 2.24M | 1.85M | 1.27M | 1.17M | 1.15M | 1.15M | 1.13M | 0.99M | |||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.38M | 0.39M | 0.41M | 0.47M | 0.52M | 1.01M | 1.03M | 1.08M | 0.99M | 1.10M | 1.17M | 1.19M | 1.19M | 1.10M | 1.05M | 1.17M | 1.26M | 1.22M | 1.27M | 1.28M | |||||||
| Change in Working Capital | |||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.43M | -0.74M | -0.05M | ||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.80M | 1.66M | -1.68M | 0.23M | -1.70M | 1.51M | -0.33M | 0.95M | 1.37M | -1.09M | 0.70M | -0.79M | -0.51M | 1.46M | -0.23M | 4.55M | -1.84M | 4.30M | 3.53M | -4.06M | |||||||
| Change in Accured ExpensesChange Accured Exp. | 1.06M | 0.54M | -1.07M | 0.65M | 1.08M | 1.82M | -3.40M | 1.16M | 3.61M | 2.00M | -2.39M | 3.17M | 8.11M | -2.37M | -2.31M | 3.11M | 4.98M | 2.37M | -4.12M | 6.54M | |||||||
| Other Working Capital ChangesOther WC Changes | -0.62M | 0.35M | -1.22M | -0.16M | -0.50M | -1.25M | -0.30M | -0.24M | -0.20M | 0.02M | 0.08M | -0.01M | -0.00M | -0.01M | -0.01M | -0.09M | -0.09M | 1.38M | 0.83M | ||||||||
| Investing Activities | |||||||||||||||||||||||||||
| Capital ExpendituresCapex | 2.63M | 5.10M | 6.41M | 2.07M | 1.96M | 1.09M | 1.01M | 0.81M | 0.41M | 0.55M | 0.71M | 0.93M | 1.20M | 0.95M | 2.78M | 2.35M | -0.01M | -0.19M | 0.67M | -0.02M | |||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 5.00M | 12.00M | 65.72M | 205.28M | -135.19M | 58.87M | 55.52M | 30.39M | 28.51M | 14.78M | 23.57M | 64.87M | 65.79M | 166.66M | 101.62M | 32.93M | 49.18M | 102.40M | 87.65M | ||||||||
| Cash from Investing ActivitiesCash from Investing | -139.01M | -32.29M | -54.11M | 57.47M | 15.37M | -35.78M | 43.13M | 49.29M | 29.98M | -6.68M | -263.26M | -73.54M | 27.30M | 7.06M | 31.95M | -13.85M | 17.78M | -128.85M | 68.89M | 25.54M | |||||||
| Financing Activities | |||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.43M | 0.88M | 1.42M | -0.76M | 3.11M | ||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.98M | 116.14M | 0.63M | -0.05M | 0.46M | 2.05M | 10.99M | 130.52M | 10.56M | 4.76M | 318.83M | 17.25M | 0.57M | 0.60M | 0.86M | 0.12M | 111.98M | 11.48M | 42.34M | ||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.57M | 1.17M | 2.71M | 1.06M | 3.82M | 0.29M | 1.82M | 1.42M | 2.40M | 2.66M | |||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 114.30M | 9.65M | 120.07M | -0.51M | 315.72M | 281.25M | 0.00M | 9.81M | 21.84M | ||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||
| Change in Cash | -152.75M | 62.01M | -77.03M | 37.51M | -5.19M | -55.95M | 26.22M | 157.74M | 39.37M | -26.57M | 26.49M | -86.53M | -1.52M | -38.20M | -15.81M | -56.37M | -28.60M | 11.69M | 12.25M | -2.12M | |||||||
| Free Cash FlowFCF | -18.36M | -26.93M | -29.96M | -21.97M | -22.98M | -23.31M | -28.92M | -22.87M | -1.58M | -25.20M | -29.80M | -31.17M | -30.59M | -46.81M | -50.54M | -45.72M | -46.49M | 28.74M | -68.80M | -69.98M | |||||||
| Net Cash FlowNCF | -152.75M | 62.01M | -77.03M | 37.51M | -5.19M | -55.95M | 26.22M | 157.74M | 39.37M | -26.57M | 26.49M | -86.53M | -1.52M | -38.20M | -15.81M | -56.37M | -28.60M | 11.69M | 12.25M | -2.12M |